Article Listing - Meda acquires rights to Orexo drugs

EUROPEAN ASTHMA TREATMENT MARKET

6 April 1992

Sales of beta-2 agonists in Europe will grow from $485 million in 1990 to almost $983 million by 1995, or...

LOWER SALES/PROFIT FOR BAYER ITALY

6 April 1992

In line with the group's overall international performance, Bayer Italia reports lower sales and profits in 1991. The subsidiary of...

FUTURE PRODUCTS FROM GENETICS INSTITUTE

6 April 1992

Highlighting the most prominent products and product candidates in its commercial development pipeline, Genetics Institute acknowledges that significant progress has...

ASPIRIN HELPS BAYER IN ITALY

6 April 1992

Favorable trends in drugs business and especially good sales of standard products such as aspirin are reported to have helped...

US HOSPITAL FORMULARY GUIDE

6 April 1992

The American Society of Hospital Pharmacists has released guidelines on formulary system management for its members.

The ASHP notes that in...

DURAMED'S ISONIAZID

6 April 1992

The resurgence of tuberculosis brought about by the AIDS epidemic has caused generic drugs company Duramed Pharmaceut-icals to resume manufacture...

MILES STAFF CUTS

6 April 1992

Miles Inc of the USA is to reduce its workforce at its Diagnostics Business Group by 600, around 9%. The...

ARES-SERONO GAINS RIGHTS TO CUROSURF

6 April 1992

Swiss pharmaceutical group Ares-Serono has acquired exclusive marketing rights in most European territories for a natural pulmonary surfactant product, Curosurf,...

STOCK MARKET COMMENTARY: NEW YORK

6 April 1992

NEW YORK: share prices moved up and down during the reporting week, first with lower car sales pushing the Dow...

ICH STEERING COMMITTEE MEETING

6 April 1992

The Steering Committee for the Second International Conference on Harmonization (ICH) of technical requirements for the registration of pharmaceutical products...